Get my own profile
Public access
View all35 articles
2 articles
available
not available
Based on funding mandates
Co-authors
Mikhail SavitskiEMBLVerified email at embl.de
Nassos TypasGroup Leader, EMBLVerified email at embl.de
Frank SteinEMBL HeidelbergVerified email at embl.de
Per ArturssonUppsala universityVerified email at farmaci.uu.se
Nils KurzawaCellzome, a GSK companyVerified email at gsk.com
Isabelle BecherEMBL HeidelbergVerified email at embl.de
Pär MatssonProfessor of Pharmacokinetics, Sahlgrenska Academy, University of GothenburgVerified email at gu.se
Joel SelkrigRWTH University Hospital, Aachen, GermanyVerified email at ukaachen.de
Dominic HelmProteomics Core Facility, DKFZVerified email at dkfz-heidelberg.de
Manuel BanzhafUniversity of Birmingham, EnglandVerified email at bham.ac.uk
Cristina ViéitezSenior Scientist at IMSB, ETH ZurichVerified email at embl.de
Thomas LundbäckSenior Director, Mechanistic & Structural Biology, R&D, AstraZenecaVerified email at astrazeneca.com
mike hannGlaxoSmithKlineVerified email at gsk.com
Ana Rita BrochadoWürzburg UniversityVerified email at uni-wuerzburg.de
Brinton Seashore-LudlowKarolinska InstitutetVerified email at ki.se
Christine WeglerPostdoctoral researcher, Molecular Biology, Umeå UniversityVerified email at umu.se
Anna VildhedeSenior scientist, AstraZenecaVerified email at alumni.chalmers.se
Bede P. BusbySenior Scientist Ministry for Primary Industries, Bacteriology and Aquatic Animal DiseasesVerified email at mpi.govt.nz
Magnus ÖlanderPostdoctoral researcher, Department of Molecular Biology, Umeå UniversityVerified email at umu.se
Felipe CavaUmeå University (Sweden)Verified email at umu.se
Follow
André Mateus
Assistant Professor at Umeå University | Team Leader at Molecular Infection Medicine Sweden (MIMS)
Verified email at umu.se - Homepage